An Open-label Pilot Study Evaluating the Effect of a Combination Regimen of Herceptin, Cisplatin, and Gemcitabine on Time to Disease Progression in Patients With Metastatic Urothelial Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2015
At a glance
- Drugs Trastuzumab (Primary) ; Cisplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- Sponsors Roche
- 16 Feb 2015 Last checked against ClinicalTrials.gov record.
- 16 Dec 2013 New source identified and integrated, ClinicalTrials.gov record.
- 23 Feb 2010 Status changed from recruiting to completed as reported by Roche Record.